BATTLE FOR WORLD | July 18, 2020: The Russian pharmaceutical company R-Pharm has signed an agreement with the "British-Swedish AstraZeneca and the University of Oxford" alliance for the production of a coronavirus vaccine developed by them. The vaccine is currently undergoing testing to determine how well it protects against coronavirus, as well as estimating its safety and immune response in humans.

The plan is to supply the drug to 30-50 countries, said Chairman of the Board of Directors of the Russian company, Alexey Repik, in an interview with Rossiya 24 TV channel.

Further adding: "We formalized this intention in the form of a signed agreement on production and supply of a vaccine that was developed by AstraZeneca and the University of Oxford, using the technological capabilities of R-Pharm to implement the project. Moreover, R-Pharm will act as a kind of hub for vaccine supplies to a huge number of countries - to 30, 40, 50 countries, including the countries of the Middle East, including the countries of Southeast Asia, European countries, of course, the CIS, and Russia," said Repik.

END